BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Drug Development

  Medgenics, Inc. Acquires Phase II-Ready CNS Program: NFC-1

  September 9, 2015

   · 

  7 min read
• Drug Development

  Flexion Tanks as Lead Drug Flunks Pivotal Phase IIb Clinical Trial

  September 9, 2015

   · 

  6 min read
• Drug Development

  GlaxoSmithKline And Theravance Announce Results From The SUMMIT COPD CV Survival Study

  September 9, 2015

   · 

  19 min read
• Drug Development

  TetraPhase Sinks 80% Premarket as Eravacycline Fails to Meet Phase III Trial Goals

  September 9, 2015

   · 

  9 min read
• Business

  Dow AgroSciences LLC Announces License Agreement With Critical Path Services

  September 9, 2015

   · 

  3 min read
• Drug Development

  Ophthotech Corporation To Present At The Morgan Stanley Global Healthcare Conference

  September 9, 2015

   · 

  1 min read
• Drug Development

  GenKyoTex S.A. Announces Top-Line Results Of Phase 2 Clinical Program

  September 9, 2015

   · 

  2 min read
• Drug Development

  FDA Grants Genentech’s Alectinib Priority Review For Specific Type Of ALK-Positive Lung Cancer

  September 9, 2015

   · 

  5 min read
• BioForest

  Starnes’ Physician-Sponsored IDE Study Gains FDA Approval To Add More AAA Devices & Introduce Planning Tool

  September 9, 2015

   · 

  5 min read
• Drug Development

  AstraZeneca PLC Presents Further Evidence For The Potential Of AZD9291 In First-Line And Pre-Treated Non-Small Cell Lung Cancer

  September 9, 2015

   · 

  7 min read